Marlise R. Luskin - Concepedia

Author

Marlise R. Luskin

Also Known As

M. R. Luskin, M.R. Luskin, Marlise Luskin, Marlise R Luskin, Marlise R. Luskin, Marlise Rachael Luskin, Marlise Rachel Luskin

422

Publications

Citations

H-Index

112

Concepts

All Affiliations

Dana-Farber Cancer Institute Massachusetts General Hospital Harvard University Brigham and Women's Hospital University of Pennsylvania

About

Marlise R. Luskin is an author at Dana-Farber Cancer Institute specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	30	1.5K
2	Health Sciences	7	7	162
3	Public Health	5	5	341
4	Education	1	1	44
5	Allergy	1	1	72

Marlise R. Luskin

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Blood	2017	281
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis Lachelle D. Weeks, Abhishek Niroula, Donna Neuberg, NEJM Evidence	2023	265
Parental acceptance of the human papillomavirus vaccine Elyse Olshen, Elizabeth R. Woods, S. Bryn Austin, Journal of Adolescent Health VaccinationVaccine SafetyPreventive MedicineCervical CancerHuman Papillomavirus Vaccines	2005	245
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★ Ran Reshef, Saran Vardhanabhuti, Marlise R. Luskin, American Journal of Transplantation TransplantationAutoimmune DiseaseImmunosuppressive TherapyTransplantation MedicineHematology	2011	216
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms Debra Van Egeren, Javier Escabi, Maximilian Nguyen, Cell stem cell	2021	204
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder Marlise R. Luskin, Daniel S. Heil, Kay See Tan, American Journal of Transplantation Posttransplantation Lymphoproliferative DisorderTransplantationHematologyImmunologyPathology	2015	171
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups Marlise R. Luskin, Ju-Whei Lee, Hugo F. Fernández, Blood	2016	127
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i> -Mutated Myeloid Malignancies Curtis A. Lachowiez, Sanam Loghavi, Zhihong Zeng, Blood Cancer Discovery	2023	114
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis Haijiao Zhang, Beth Wilmot, Daniel Bottomly, Blood	2019	84
Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro John C. Tilton, Maura Manion, Marlise R. Luskin, Journal of Virology Primary ImmunodeficiencyType 1Purified PdcMedicineHuman Retrovirus	2008	80

Page 1